RETRACTED: Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3. (Q39887458)

From Wikidata

Jump to navigation Jump to search

retracted scientific article

Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.

Language	Label	Description	Also known as
English	RETRACTED: Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.	retracted scientific article	Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

RETRACTED: Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

based on heuristic

inferred from title

cellular senescence

1 reference

based on heuristic

inferred from title

author name string

Lucy Cassar

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Craig Nicholls

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Alex R Pinto

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

He Li

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Jun-Ping Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

4 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1880-1892

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

Intrinsic tumour suppression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Telomerase therapeutics for cancer: challenges and new directions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Renal Fibrosis and Glomerulosclerosis in a New Mouse Model of Diabetic Nephropathy and Its Regression by Bone Morphogenic Protein-7 and Advanced Glycation End Product Inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

p16INK4a as a second effector of the telomere damage pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Signal transduction by the TGF-beta superfamily

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Protection of mammalian telomeres

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Telomeres and human disease: ageing, cancer and beyond

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Bone morphogenetic proteins in development

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

The disparate role of BMP in stem cell biology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Telomerase down-regulation does not mediate PC12 pheochromocytoma cell differentiation induced by NGF, but requires MAP kinase signalling.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Direct activation of TERT transcription by c-MYC.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Modulation of allograft incorporation by continuous infusion of growth factors over a prolonged duration in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

BMP7 signaling in renal development and disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Smad transcription factors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Regulation of telomerase activity in immortal cell lines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Different telomere damage signaling pathways in human and mouse cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Dynamin II regulates hormone secretion in neuroendocrine cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1096/FJ.08-119529

Identifiers

10.1096/FJ.08-119529

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39887458&oldid=2092119884"